It appears that much like c-Met, EGFR has the potential to be a master regulator of the tumour niche, thanks to its capacity for horizontal transfer and its multiple interactions with other RTKs both from its own family and from the wider RTK superfamily (see, for example, in [145,183,184,185,186,187]). Here, EGFR is linked to neoplasm.